Interestingly, the analysis of the TCGA dataset from 335 prostate cancer patients [27] demonstrated that this SNP appears to have no effect on most of these genes except for SLC22A1 and SLC22A3 (Supplementary Figure S2). This evidence concerns the gene SLC22A3 and prostate cancer.